Osteoporosis — Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Citation(s)
Efficacy of a Single Infusion of Zoledronic Acid to Mitigate the Rebound Effect of Rapid Bone Loss Following Denosumab Treatment Discontinuation